Top 5 Stocks to Buy Now
→ SpaceX will mint billionaires. You won't be one of them. (From Behind the Markets) (Ad)tc pixel Free OCEAW Stock Alerts

Ocean Biomedical (OCEAW) Competitors

Compare

OCEAW vs. AIMDW, ALVOW, ARAV, ACABW, and BFRIW

Should you buy Ocean Biomedical stock or one of its competitors? MarketBeat compares Ocean Biomedical with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Ocean Biomedical include Ainos (AIMDW), Alvotech (ALVOW), Aravive (ARAV), Atlantic Coastal Acquisition Corp. II (ACABW), and Biofrontera (BFRIW). These companies are all part of the "pharmaceutical products" industry.

How does Ocean Biomedical compare to Ainos?

Ocean Biomedical (NASDAQ:OCEAW) and Ainos (NASDAQ:AIMDW) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, risk, profitability, institutional ownership, media sentiment, valuation, earnings and analyst recommendations.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ocean BiomedicalN/AN/AN/AN/AN/A
Ainos$18.11KN/AN/AN/AN/A

In the previous week, Ocean Biomedical's average media sentiment score of 0.00 equaled Ainos'average media sentiment score.

Company Overall Sentiment
Ocean Biomedical Neutral
Ainos Neutral

Company Net Margins Return on Equity Return on Assets
Ocean BiomedicalN/A N/A N/A
Ainos N/A N/A N/A

Summary

Ainos beats Ocean Biomedical on 1 of the 1 factors compared between the two stocks.

How does Ocean Biomedical compare to Alvotech?

Ocean Biomedical (NASDAQ:OCEAW) and Alvotech (NASDAQ:ALVOW) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, dividends, media sentiment, risk, institutional ownership, profitability, valuation and earnings.

In the previous week, Ocean Biomedical's average media sentiment score of 0.00 equaled Alvotech'saverage media sentiment score.

Company Overall Sentiment
Ocean Biomedical Neutral
Alvotech Neutral

Company Net Margins Return on Equity Return on Assets
Ocean BiomedicalN/A N/A N/A
Alvotech N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ocean BiomedicalN/AN/AN/AN/AN/A
Alvotech$559.42MN/AN/AN/AN/A

Summary

Alvotech beats Ocean Biomedical on 1 of the 1 factors compared between the two stocks.

How does Ocean Biomedical compare to Aravive?

Ocean Biomedical (NASDAQ:OCEAW) and Aravive (NASDAQ:ARAV) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their media sentiment, dividends, profitability, risk, analyst recommendations, valuation, earnings and institutional ownership.

35.8% of Aravive shares are held by institutional investors. 60.4% of Aravive shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

In the previous week, Ocean Biomedical's average media sentiment score of 0.00 equaled Aravive'saverage media sentiment score.

Company Overall Sentiment
Ocean Biomedical Neutral
Aravive Neutral

Company Net Margins Return on Equity Return on Assets
Ocean BiomedicalN/A N/A N/A
Aravive N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ocean BiomedicalN/AN/AN/AN/AN/A
AraviveN/AN/AN/A-$0.90N/A

Summary

Aravive beats Ocean Biomedical on 2 of the 2 factors compared between the two stocks.

How does Ocean Biomedical compare to Atlantic Coastal Acquisition Corp. II?

Atlantic Coastal Acquisition Corp. II (NASDAQ:ACABW) and Ocean Biomedical (NASDAQ:OCEAW) are both pharmaceutical products companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, profitability, valuation, institutional ownership, risk, dividends, earnings and analyst recommendations.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Atlantic Coastal Acquisition Corp. IIN/AN/AN/AN/AN/A
Ocean BiomedicalN/AN/AN/AN/AN/A

In the previous week, Atlantic Coastal Acquisition Corp. II's average media sentiment score of 0.00 equaled Ocean Biomedical'saverage media sentiment score.

Company Overall Sentiment
Atlantic Coastal Acquisition Corp. II Neutral
Ocean Biomedical Neutral

Company Net Margins Return on Equity Return on Assets
Atlantic Coastal Acquisition Corp. IIN/A N/A N/A
Ocean Biomedical N/A N/A N/A

Summary

Atlantic Coastal Acquisition Corp. II and Ocean Biomedical tied by winning 0 of the 0 factors compared between the two stocks.

How does Ocean Biomedical compare to Biofrontera?

Ocean Biomedical (NASDAQ:OCEAW) and Biofrontera (NASDAQ:BFRIW) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their dividends, profitability, analyst recommendations, institutional ownership, earnings, valuation, risk and media sentiment.

In the previous week, Ocean Biomedical's average media sentiment score of 0.00 equaled Biofrontera'saverage media sentiment score.

Company Overall Sentiment
Ocean Biomedical Neutral
Biofrontera Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ocean BiomedicalN/AN/AN/AN/AN/A
Biofrontera$43.20MN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
Ocean BiomedicalN/A N/A N/A
Biofrontera N/A N/A N/A

Summary

Biofrontera beats Ocean Biomedical on 1 of the 1 factors compared between the two stocks.

Get Ocean Biomedical News Delivered to You Automatically

Sign up to receive the latest news and ratings for OCEAW and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

OCEAW vs. The Competition

Export
MetricOcean BiomedicalBiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$381.56M$6.43B$12.59B
Dividend YieldN/A3.86%2.68%5.81%
P/E RatioN/A3.1224.7524.43
Price / SalesN/A6,861.77529.99108.89
Price / CashN/A13.1345.0755.09
Price / BookN/A92.2610.806.58
Net IncomeN/A-$96.07M$3.57B$337.17M

Ocean Biomedical Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
OCEAW
Ocean Biomedical
N/AN/AN/AN/A$0.00N/AN/A2
AIMDW
Ainos
N/A$0.49
+273.8%		N/A-48.8%$0.00$18.11KN/A40
ALVOW
Alvotech
N/A$0.27
-9.0%		N/AN/A$0.00$586.32MN/A4
ARAV
Aravive
N/A$0.04
flat		N/AN/A$0.00N/AN/A20
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.00
flat		N/AN/A$0.00N/AN/A15

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:OCEAW) was last updated on 6/21/2026 by MarketBeat.com Staff.
From Our Partners
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
This is the worst news for stocks in 50 years
Goldman Sachs and Morgan Stanley are issuing a rare warning: what's ahead for U.S. stocks could be the worst e...
TradeSmith | Sponsoredtc pixel
A huge SpaceX error just led one stock to 3X move!
SPCE surged roughly 300% in a single week after investors hunting SpaceX exposure piled into the wrong ticker....
InvestPub | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel
The roadshow starts Monday. This stock isn't ready.
The SpaceX roadshow kicks off June 8. Goldman Sachs, the lead underwriter, will present the full S-1 to the wo...
Behind the Markets | Sponsoredtc pixel
Hey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...
After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...
Banyan Hill Publishing | Sponsoredtc pixel